RxDoctor Payments Data

Marcus Cox, MD

Interventional Cardiology · New Iberia, LANPI 1538681945

Payments from drug & device makers

What this record shows

This record is dominated by grants: $17,000 of the $26,511 with a category attached, or 64.1%. 34 manufacturers reported payments, led by Abbott at 40.7% of the total. Reporting peaked in 2023 at $18,051 and has fallen 75.1% since, to $4,494 in 2025.

$26,511in general payments, 2019–2025

Across 173 payments — averaging $153.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$11K
  • Medtronic$8K
  • Penumbra, Inc.$2K
  • Abiomed$681
  • Angiodynamics, Inc.$664
  • Boston Scientific$560
  • plus $4K from 28 others

What the payments were for

  • Grants$17,00064%
  • Travel & lodging$2,4389%
  • Food & beverage$6,92826%
  • Education$1461%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,511 in reported general payments places this provider in the 75th percentile of 171 interventional cardiology providers in Louisiana.

See all interventional cardiology providers in Louisiana

Medicare billing

Part B allowed, 2024
$36,280
Medicare patients
134
Services billed
371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate20$180
Atorvastatin Calcium17$117
Amlodipine Besylate16$100

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in New Iberia

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →